The SPDR S&P Biotech ETF (XBI) provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. For XBI Options Trading, they trade with only Friday expirations priced in increments of $0.50. and are a very popular, low priced play which can often provide weekly gains of over 5,000%.
2017 – 2019 Ranges: (58.66 – 88.98) (64.38 – 101.55) (70.20 – 98.79)
Get the 32Trades 5day & 10day Trade Forecast view by clicking here
Weekly Chart
Daily Chart
5 Day Chart
Get the 32Trades 5day & 10day Trade Forecast view by clicking here
Pivot Points
(updated weekly after Friday’s close)
| Support/Resistance Levels | Price | Key Turning Points |
|---|---|---|
| 14 Day RSI at 80% | 156.48 | |
| 14 Day RSI at 70% | 132.12 | |
| 13-Week High | 121.06 | |
| 52-Week High | 121.06 | |
| 1-Month High | 121.06 | |
| 115.95 | 38.2% Retracement From 4 Week High | |
| 114.38 | 50% Retracement From 4 Week High/Low | |
| 112.80 | 38.2% Retracement From 4 Week Low | |
| 112.63 | 14 Day RSI at 50% | |
| Last | 109.33 | Last |
| 108.98 | 38.2% Retracement From 13 Week High | |
| 1-Month Low | 107.69 | |
| 105.25 | 50% Retracement From 13 Week High/Low | |
| 101.53 | 38.2% Retracement From 13 Week Low | |
| 98.86 | 38.2% Retracement From 52 Week High | |
| 14 Day RSI at 30% | 97.53 | |
| 92.00 | 50% Retracement From 52 Week High/Low | |
| 13-Week Low | 89.45 | |
| 85.14 | 38.2% Retracement From 52 Week Low | |
| 14 Day RSI at 20% | 78.67 | |
| 52-Week Low | 62.94 |
